Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - CHANGE IN WORKING CAPITAL
Change in Working Capital KROS - Keros Therapeutics, Inc.
-2.65 M
LAST VALUE
59.39%
2 YEAR CAGR
-5.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR